Caspases: the proteases of the apoptotic pathway
- PMID: 9916986
- DOI: 10.1038/sj.onc.1202581
Caspases: the proteases of the apoptotic pathway
Abstract
Apoptosis, a morphologically defined form of physiological cell death, is implemented by a death machinery whose executionary arm is a family of cysteine proteases called caspases. These death proteases are part of a proteolytic caspase cascade that is activated by diverse apoptotic stimuli from outside and inside of the cell. The cell death machinery is evolutionarily conserved and composed of caspases and their regulatory components that include activators and repressors. These key components of the death machinery are linked to signaling pathways that are activated by either ligation of death receptors expressed at the cell surface or intracellular death signals. Caspases are normally present in the cell as proenzymes that require limited proteolysis for activation of enzymatic activity. Recent studies suggest that the basic mechanism of caspase activation is conserved in evolution. Binding of initiator caspase precursors to activator molecules appears to promote procaspase oligomerization and autoactivation. Enzymatic activation of initiator caspases leads to proteolytic activation of downstream (effector) caspases and cleavage of a number of vital proteins, resulting in the orderly demise and removal of the cell.
Similar articles
-
Bcl-2 regulates a caspase-3/caspase-2 apoptotic cascade in cytosolic extracts.Oncogene. 1999 Mar 11;18(10):1781-7. doi: 10.1038/sj.onc.1202490. Oncogene. 1999. PMID: 10086332
-
Activation of caspases occurs downstream from radical oxygen species production, Bcl-xL down-regulation, and early cytochrome C release in apoptosis induced by transforming growth factor beta in rat fetal hepatocytes.Hepatology. 2001 Sep;34(3):548-56. doi: 10.1053/jhep.2001.27447. Hepatology. 2001. PMID: 11526541
-
Cisplatin-induced apoptosis proceeds by caspase-3-dependent and -independent pathways in cisplatin-resistant and -sensitive human ovarian cancer cell lines.Cancer Res. 1999 Jul 1;59(13):3077-83. Cancer Res. 1999. PMID: 10397248
-
Caspases and cancer: mechanisms of inactivation and new treatment modalities.Exp Oncol. 2004 Jun;26(2):82-97. Exp Oncol. 2004. PMID: 15273659 Review.
-
Caspase-8 in apoptosis: the beginning of "the end"?IUBMB Life. 2000 Aug;50(2):85-90. doi: 10.1080/713803693. IUBMB Life. 2000. PMID: 11185963 Review.
Cited by
-
5,7-Dihydroxyflavone Enhances the Apoptosis-Inducing Potential of TRAIL in Human Tumor Cells via Regulation of Apoptosis-Related Proteins.Evid Based Complement Alternat Med. 2013;2013:434709. doi: 10.1155/2013/434709. Epub 2013 Feb 28. Evid Based Complement Alternat Med. 2013. PMID: 23533482 Free PMC article.
-
Anticancer Effect of PtIIPHENSS, PtII5MESS, PtII56MESS and Their Platinum(IV)-Dihydroxy Derivatives against Triple-Negative Breast Cancer and Cisplatin-Resistant Colorectal Cancer.Cancers (Basel). 2024 Jul 15;16(14):2544. doi: 10.3390/cancers16142544. Cancers (Basel). 2024. PMID: 39061185 Free PMC article.
-
Chemotherapeutic drugs: Cell death- and resistance-related signaling pathways. Are they really as smart as the tumor cells?Transl Oncol. 2021 May;14(5):101056. doi: 10.1016/j.tranon.2021.101056. Epub 2021 Mar 6. Transl Oncol. 2021. PMID: 33684837 Free PMC article. Review.
-
Induction of apoptosis in human prostate cancer cell line, PC3, by 3,3'-diindolylmethane through the mitochondrial pathway.Br J Cancer. 2004 Oct 4;91(7):1358-63. doi: 10.1038/sj.bjc.6602145. Br J Cancer. 2004. PMID: 15328526 Free PMC article.
-
Molecular pathways in cerebral ischemia: cues to novel therapeutic strategies.Mol Neurobiol. 2003 Feb;27(1):33-72. doi: 10.1385/MN:27:1:33. Mol Neurobiol. 2003. PMID: 12668901 Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources